Clinical Trials
9
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Intraprostatic PRX302 Injection to Treat Localised Prostate Cancer
- First Posted Date
- 2017-03-16
- Last Posted Date
- 2019-04-10
- Lead Sponsor
- Sophiris Bio Corp
- Target Recruit Count
- 38
- Registration Number
- NCT03081481
- Locations
- 🇺🇸
Vantage Health, Ocala, Florida, United States
🇺🇸Chesapeake Urology Associates, Baltimore, Maryland, United States
🇺🇸New York Urology Associates, New York, New York, United States
Evaluate, Safety and Tolerability of Intraprostatic PRX302 Administration, Low to Intermediate Risk Prostate Cancer
- First Posted Date
- 2015-07-16
- Last Posted Date
- 2016-07-27
- Lead Sponsor
- Sophiris Bio Corp
- Target Recruit Count
- 18
- Registration Number
- NCT02499848
- Locations
- 🇬🇧
UCLH, London, United Kingdom
Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH
- First Posted Date
- 2013-10-21
- Last Posted Date
- 2017-04-27
- Lead Sponsor
- Sophiris Bio Corp
- Target Recruit Count
- 479
- Registration Number
- NCT01966614
Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH)
- First Posted Date
- 2011-10-19
- Last Posted Date
- 2013-08-21
- Lead Sponsor
- Sophiris Bio Corp
- Target Recruit Count
- 40
- Registration Number
- NCT01454349
- Locations
- 🇺🇸
South Orange County Medical Research Center, Laguna Hills, California, United States
🇺🇸Atlantic Urology Medical Group, Long Beach, California, United States
🇺🇸California Professional Research, Newport Beach, California, United States
Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic Hyperplasia
- First Posted Date
- 2009-04-29
- Last Posted Date
- 2018-11-21
- Lead Sponsor
- Sophiris Bio Corp
- Target Recruit Count
- 92
- Registration Number
- NCT00889707
- Locations
- 🇨🇦
Andreou Research, Surrey, British Columbia, Canada
🇨🇦CanMed Clinical Research Inc., Victoria, British Columbia, Canada
🇨🇦Dr. Steinhoff Clinical Research, Victoria, British Columbia, Canada
- Prev
- 1
- 2
- Next